Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luce Boyer

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The American Journal of Medicine|July 11, 2002
Is anteroseptal myocardial infarction an appropriate term?Peter Bogaty, Luce Boyer, Léon Rousseau, et al.
Circulation|April 1, 2003
What induces the warm-up ischemia/angina phenomenon: exercise or myocardial ischemia?Peter Bogaty, Paul Poirier, Luce Boyer, et al.
The Canadian Journal of Cardiology|November 5, 2019
Variability in High-Sensitivity Cardiac Troponin T Testing in Stable Patients With and Without Coronary Artery DiseaseJames M Brophy, Gilles R Dagenais, Luce Boyer, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 31, 2009
Therapeutic management in patients with renal failure who experience an acute coronary syndromeHéloise Cardinal, Peter Bogaty, Francois Madore, et al.
American Heart Journal|October 18, 2008
Effects of exogenous metabolic substrate modulation on exercise-induced myocardial ischemiaPeter Bogaty, Paul Poirier, Luce Boyer, et al.
The American Journal of Cardiology|June 12, 2010
Genetic polymorphisms and the cardiovascular risk of non-steroidal anti-inflammatory drugsChristine G St Germaine, Peter Bogaty, Luce Boyer, et al.
Plos One|April 13, 2013
Time variability of C-reactive protein: implications for clinical risk stratificationPeter Bogaty, Gilles R Dagenais, Lawrence Joseph, et al.
Archives of Internal Medicine|January 26, 2005
Fluctuating inflammatory markers in patients with stable ischemic heart diseasePeter Bogaty, James M Brophy, Luce Boyer, et al.
Circulation|August 11, 2004
Impact of prolonged cyclooxygenase-2 inhibition on inflammatory markers and endothelial function in patients with ischemic heart disease and raised C-reactive protein: a randomized placebo-controlled studyPeter Bogaty, James M Brophy, Martin Noel, et al.
The American Journal of Cardiology|March 10, 2010
Usefulness of soluble fas levels for improving diagnostic accuracy and prognosis for acute coronary syndromesHéloise Cardinal, James M Brophy, Peter Bogaty, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The American Journal of Medicine|July 11, 2002
Is anteroseptal myocardial infarction an appropriate term?Peter Bogaty, Luce Boyer, Léon Rousseau, et al.
Circulation|April 1, 2003
What induces the warm-up ischemia/angina phenomenon: exercise or myocardial ischemia?Peter Bogaty, Paul Poirier, Luce Boyer, et al.
The Canadian Journal of Cardiology|November 5, 2019
Variability in High-Sensitivity Cardiac Troponin T Testing in Stable Patients With and Without Coronary Artery DiseaseJames M Brophy, Gilles R Dagenais, Luce Boyer, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 31, 2009
Therapeutic management in patients with renal failure who experience an acute coronary syndromeHéloise Cardinal, Peter Bogaty, Francois Madore, et al.
American Heart Journal|October 18, 2008
Effects of exogenous metabolic substrate modulation on exercise-induced myocardial ischemiaPeter Bogaty, Paul Poirier, Luce Boyer, et al.
The American Journal of Cardiology|June 12, 2010
Genetic polymorphisms and the cardiovascular risk of non-steroidal anti-inflammatory drugsChristine G St Germaine, Peter Bogaty, Luce Boyer, et al.
Plos One|April 13, 2013
Time variability of C-reactive protein: implications for clinical risk stratificationPeter Bogaty, Gilles R Dagenais, Lawrence Joseph, et al.
Archives of Internal Medicine|January 26, 2005
Fluctuating inflammatory markers in patients with stable ischemic heart diseasePeter Bogaty, James M Brophy, Luce Boyer, et al.
Circulation|August 11, 2004
Impact of prolonged cyclooxygenase-2 inhibition on inflammatory markers and endothelial function in patients with ischemic heart disease and raised C-reactive protein: a randomized placebo-controlled studyPeter Bogaty, James M Brophy, Martin Noel, et al.
The American Journal of Cardiology|March 10, 2010
Usefulness of soluble fas levels for improving diagnostic accuracy and prognosis for acute coronary syndromesHéloise Cardinal, James M Brophy, Peter Bogaty, et al.
Pageof 2